Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial

BACKGROUND: Improved treatment for onchocerciasis is needed to accelerate onchocerciasis elimination in Africa. Aiming to better exploit registered drugs, this study was undertaken to determine whether annual or semiannual treatment with ivermectin (IVM; 200 µg/kg) plus albendazole (ALB; 800 mg sing...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Infect Dis
Egile Nagusiak: Batsa Debrah, Linda, Klarmann-Schulz, Ute, Osei-Mensah, Jubin, Dubben, Bettina, Fischer, Kerstin, Mubarik, Yusif, Ayisi-Boateng, Nana Kwame, Ricchiuto, Arcangelo, Fimmers, Rolf, Konadu, Peter, Nadal, Jennifer, Gruetzmacher, Barbara, Weil, Gary, Kazura, James W, King, Christopher L, Debrah, Alexander Y, Hoerauf, Achim
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2020
Gaiak:
Articles and Commentaries
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7428389/
https://ncbi.nlm.nih.gov/pubmed/31536624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz889
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak